NCT00906646View on ClinicalTrials.gov

Preparation of Patients for Cardiac Surgery

PHASE3CompletedINTERVENTIONAL
Enrollment

117

Participants

Timeline

Start Date

April 30, 2004

Primary Completion Date

June 30, 2006

Study Completion Date

December 31, 2008

Conditions
Coronary Artery Bypass Graft SurgeryCardiac Valve Surgery
Interventions
DIETARY_SUPPLEMENT

Metabolic therapy

Coenzyme Q10 - 100 mg tds Magnesium orotate - 400 mg tds Lipoic acid - 100 mg tds Omega-3 fatty acids - 300 mg (in 1 g fish oils) tds Selenium - 200 µg

DIETARY_SUPPLEMENT

Placebo

Placebo tablets

Trial Locations (1)

3004

The Alfred Hospital, Melbourne

Sponsors

Lead Sponsor

Bayside Health
All Listed Sponsors
collaborator

Griffith University

OTHER

lead

Bayside Health

OTHER_GOV

NCT00906646 - Preparation of Patients for Cardiac Surgery | Biotech Hunter | Biotech Hunter